AGTR1 and diabetic cardiomyopathy: Collectively, these results suggest that AT-II via AT1 receptor and oxidative stress play a major role in diabetes-induced myocardial apoptosis, hypertrophy and fibrosis, and treatment with either an AT1 receptor blocker or an antioxidant will be beneficial for diabetic cardiomyopathy.